ENTITY
Grifols

Grifols (GRFS US)

41
Analysis
Health Care • Spain
Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, enteral nutrition, diagnostic systems, and medical materials.
more
bullish•Grifols
•05 Aug 2026 12:43

Primer: Grifols (GRFS US) - Aug 2026

Grifols is in a turnaround phase, focusing on deleveraging its balance sheet, improving margins through operational efficiencies, and...

Logo
95 Views
Share
bullish•Grifols SA
•17 Sep 2026 12:45

Liquid Universe of European Ordinary and Preferred Shares: September '26 Report

September brought fresh dispersion: Carlsberg, Grifols and MFE widened sharply, improving convergence returns, while Ericsson's B-only buyback adds...

Share
•17 Aug 2026 12:45

Liquid Universe of European Ordinary and Preferred Shares: August '26 Report

August brought fresh dispersion across Europe's dual-class shares, creating new relative-value opportunities while corporate actions remain an...

Share
•16 Jul 2026 17:02

Liquid Universe of European Ordinary and Preferred Shares: July '26 Report

-July widened dispersion across Europe’s dual-class universe, yet selective convergence persisted beneath the surface. Structural anomalies...

Share
•17 Jun 2026 12:45

Liquid Universe of European Ordinary and Preferred Shares: June '26 Report

June brought renewed divergence across European ord/pref pairs. Structural outliers widened, convergence became more selective, and implementation...

Share
x